Callan Family Office LLC Has $236,000 Stock Holdings in Mettler-Toledo International, Inc. (NYSE:MTD)

Callan Family Office LLC reduced its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 63.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 200 shares of the medical instruments supplier’s stock after selling 343 shares during the quarter. Callan Family Office LLC’s holdings in Mettler-Toledo International were worth $236,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Greenleaf Trust lifted its stake in shares of Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock worth $1,030,000 after acquiring an additional 10 shares during the period. Sequoia Financial Advisors LLC lifted its stake in shares of Mettler-Toledo International by 1.8% in the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock worth $740,000 after acquiring an additional 11 shares during the period. Albion Financial Group UT lifted its stake in shares of Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock worth $890,000 after acquiring an additional 11 shares during the period. TD Private Client Wealth LLC lifted its stake in shares of Mettler-Toledo International by 5.4% in the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier’s stock worth $253,000 after acquiring an additional 11 shares during the period. Finally, Congress Asset Management Co. lifted its stake in shares of Mettler-Toledo International by 1.8% in the first quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier’s stock worth $788,000 after acquiring an additional 12 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Michael A. Kelly sold 1,062 shares of the company’s stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director owned 120 shares in the company, valued at approximately $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Thomas P. Salice sold 1,062 shares of the company’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director owned 283 shares of the company’s stock, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 2,424 shares of company stock worth $2,989,628 over the last quarter. 1.94% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Bank of America lifted their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a “neutral” rating in a research note on Thursday, June 26th. Barclays assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price target on the stock. UBS Group raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and dropped their price target for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Evercore ISI dropped their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Finally, Wells Fargo & Company boosted their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an “equal weight” rating in a research note on Monday, May 5th. Six equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $1,288.89.

Mettler-Toledo International Stock Up 0.2%

NYSE MTD opened at $1,315.67 on Friday. The company has a market cap of $27.10 billion, a price-to-earnings ratio of 33.32, a P/E/G ratio of 3.94 and a beta of 1.34. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,521.01. The business has a 50 day moving average price of $1,215.67 and a 200-day moving average price of $1,190.48.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%. The company’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $9.65 earnings per share. On average, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.